Lifestyle Management App for Adults With Diabetes Type
LIVEN
mHealth Lifestyle Management Program (LIVEN) For Adults With Diabetes Type 2: A Feasibility Study
1 other identifier
interventional
90
1 country
1
Brief Summary
This study will evaluate whether the 12-week health coaching mobile application (LIVEN) will succeed in enhancing lifestyle behaviors in adults with Type 2 Diabetes compared to typical treatment. The mobile application's viability will be assessed in 2 parts; the first part is testing easiness and friendliness of using Liven by the patient and health coach. The second part is evaluating the suitability of Liven education material for the patients and whether the coaching program results in enhancing lifestyle behaviors and blood sugar levels. the investigators hypothesize that the 12-week online lifestyle-coaching program will be viable, and a full-scale study can proceed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes-mellitus-type-2
Started Oct 2022
Longer than P75 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
October 10, 2022
CompletedFirst Posted
Study publicly available on registry
November 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
June 26, 2025
June 1, 2025
3.9 years
October 10, 2022
June 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
recruitment rate - descriptive
reported as the number of participants' consented divide by the number of people that were invited to participate
immediately after the intervention (3 months)
retention rates
reported as the number of participants completing all study sessions
immediately after the intervention (3 months)
User friendliness
will be assessed via user engagement tracking in the app
Daily application engagement data for each patient will be analyzed once at the end of the patient's 12 week program.
Secondary Outcomes (7)
Glycemic control - A1c
will be assessed one week prior to the intervention and one week after the end of the intervention
Glycemic control - continuous glucose mentoring (CGM)
will be assessed one week prior to the intervention and one week after the end of the intervention
Body composition - fat free mass (%) physiological parameter
will be assessed one week prior to the intervention and one week after the end of the intervention
Lifestyle behaviors - Health-Promoting Lifestyle profile II (Questionnaire)
will be assessed one week prior to the intervention and one week after the end of the intervention
physical performance assessments - upper body muscle strength in kg
will be assessed one week prior to the intervention and one week after the end of the intervention
- +2 more secondary outcomes
Study Arms (3)
interactive mhealth Lifestyle behavior intervention
EXPERIMENTALReceiving Standard care, LIVEN educational material and interactive LIVEN application
Sham group - app access only
SHAM COMPARATORReceiving standard care, LIVEN educational material and access to the application
Control group - Standard care
NO INTERVENTIONReceiving Standard care only
Interventions
Receiving Standard care, LIVEN educational material and interactive LIVEN application, via having a human component which is a health coach for 3 months
Receiving standard care, LIVEN educational material and access to the application
Eligibility Criteria
You may qualify if:
- Adults, aged 18 years or older
- Arabic speakers
- Capable of utilizing smartphones
- Diagnosed with T2DM
- Poor glycemic control: A1c \> 7.5%
You may not qualify if:
- Individuals using insulin injection
- Individuals suffering from disorders that might affect intervention (e.g. amputation, enucleation of the eye, or end-stage kidney disease)
- Women who are pregnant or breastfeeding
- Individuals diagnosed with other types of diabetes (such as type I or MODY)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Princess Nourah Bint Abdulrahman Universitylead
- Livencollaborator
Study Sites (1)
Princess Nourah bint Abdulrahman University
Riyadh, Riyadh Region, 11321, Saudi Arabia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The participant won't know if they got the full or sham or no intervention
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Scientist, Clinical Assistant Professor
Study Record Dates
First Submitted
October 10, 2022
First Posted
November 29, 2022
Study Start
October 1, 2022
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
June 26, 2025
Record last verified: 2025-06